Proteome Sciences (LON:PRM) Shares Up 9% – What’s Next?

Proteome Sciences plc (LON:PRM)’s share price shot up 9% on Friday . The company traded as high as GBX 2.18 and last traded at GBX 2.18. 87,876 shares were traded during trading, a decline of 65% from the average session volume of 248,181 shares. The stock had previously closed at GBX 2.

Proteome Sciences Stock Performance

The stock has a market cap of £6.79 million, a price-to-earnings ratio of -2.04 and a beta of 0.07. The company has a debt-to-equity ratio of -258.66, a quick ratio of 0.37 and a current ratio of 0.20. The stock’s 50-day simple moving average is GBX 2.55 and its two-hundred day simple moving average is GBX 2.88.

Proteome Sciences (LON:PRM) last released its earnings results on Thursday, September 25th. The company reported GBX (0.73) earnings per share for the quarter. Proteome Sciences had a negative return on equity of 0.01% and a negative net margin of 0.04%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.